Showing results (181-190 of 386) with videos related to
Sort By:
Pageof 39
Pigment Cell & Melanoma Research|August 3, 2016
Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferationBenjamin Izar, Cailin E Joyce, Stephanie Goff, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 2, 2024
Transmural Flow Upregulates PD-L1 Expression in Microvascular NetworksZhengpeng Wan, Shun Zhang, Amy X Zhong, et al.Nature Genetics|May 31, 2016
Landscape of tumor-infiltrating T cell repertoire of human cancersBo Li, Taiwen Li, Jean-Christophe Pignon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2018
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer ImmunotherapyF Stephen Hodi, Marcus Ballinger, Benjamin Lyons, et al.Melanoma Research|September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanomaShalin Shah, Jason J Luke, Heather A Jacene, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trialDirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.Cancer Immunology Research|May 16, 2019
The Impact of High-Dose Glucocorticoids on the Outcome of Immune-Checkpoint Inhibitor-Related Thyroid DisordersChanjuan Ma, F Stephen Hodi, Anita Giobbie-Hurder, et al.Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanomaRobert Soiffer, F Stephen Hodi, Frank Haluska, et al.Nature Communications|November 16, 2019
Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapiesJoan Montero, Cécile Gstalder, Daniel J Kim, et al.Pageof 39